Clinical Trial Update: Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating tipepidine in children with ADHD in Phase 1/2, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Disorder with Hyperactivity
• Attention Deficit and Disruptive Behavior Disorders
• Hyperkinesis

Drugs mentioned

• tipepidine (tipepidine)

Snippet

Sponsor: Chiba University | Conditions: Attention Deficit Disorder With Hyperactivity Disease, Hyperkinesis | Phase 1, Phase 2 | Status: COMPLETED